Developer docs
API playgroundTry for free, no card

Search company profiles

O2M Technologies

Full company profile

uuid0003yqo

Namestring
O2M Technologies
Legal namestring
O2M Technologies, LLC
Websiteurl
o2map.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

O2M Technologies, LLC is a Chicago-based private company that develops oxygen imaging devices and services for cancer research, regenerative medicine, and drug development. The company's foundational technology is pulsed electron paramagnetic resonance oxygen imaging (EPROI), a non-invasive method that maps absolute tissue oxygen (pO2) at approximately 0.5 mm spatial resolution using a water-soluble, non-toxic trityl spin probe. The company describes itself as the world leader in EPR oxygen imaging and its application to biomedical fields.

O2M's commercial portfolio centers on the JIVA-25®, positioned as the world's first dedicated preclinical oxygen imager, which produces absolute pO2 maps with 1 mmHg sensitivity in 1–10 minutes. The instrument is complemented by a consumables line — Trityl OXO71 and OXO63 water-soluble contrast agents — and by LiteAPM™, a 184-gram transportable small-animal physiological monitor used during imaging and surgery workflows. Together, these products constitute an integrated imaging + consumables + accessories platform for preclinical oxygen measurement.

O2M generates revenue through three streams: one-time sales of JIVA-25 instruments (capital equipment), recurring sales of Trityl contrast agents (consumables), and contract research services delivered through its Oxygen Measurement Core facility, which provides in vitro and small animal in vivo oxygen measurement from sample preparation through publication-quality data. The company pursues a sales-led go-to-market targeting academic and foundation research institutions, cancer research centers, and pharmaceutical and biotech companies. Pricing is quote-based across instruments, consumables, and services and is not publicly disclosed. Cumulative disclosed funding totals approximately $1.2 million across two NSF grants (2018 and 2021); no equity funding, named customers, or revenue figures have been disclosed.

Short descriptiontext

O2M Technologies, LLC develops oxygen imaging devices and services for cancer research, regenerative medicine, and preclinical drug development, anchored by the JIVA-25, the world's first dedicated preclinical oxygen imager using pulsed electron paramagnetic resonance technology. It sells instruments, proprietary contrast agents, and contract research services to academic and pharmaceutical customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical oxygen imaging, electron paramagnetic resonance, tissue oxygen mapping, contrast agent imaging, small animal imaging
Industry1 code
PRIMARYHLAHAGAI
Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Scientific Research and Development Services5417
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Services-Commercial Physical & Biological Research8731
Product category
Preclinical Oxygen Imaging Instruments
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Scientific Instruments (JIVA-25®)
TypeOne Time License
Description

Sale of specialized preclinical oxygen imaging instruments to research institutions and pharmaceutical companies. This represents the primary capital equipment revenue stream.

oxygenimaging.com
2Consumables (Trityl Contrast Agents)
TypeSubscription Recurring
Description

Recurring revenue from Trityl OXO71 and OXO63 contrast agents sold as powder or stock solution to existing JIVA-25 customers.

oxygenimaging.com
3Contract Research Services (Oxygen Measurement Core)
TypeProfessional Services
Description

Contract research facility offering complete in vitro and small animal in vivo oxygen measurement services — from sample prep through publication-quality data for academic, foundation, and industry partners.

oxygenimaging.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Pricing details1 tier
1Quote-based pricing for all products and services
ModelOtherBilling cadenceMulti-year contract
Notes

Instrument pricing, consumable pricing, and contract research service rates are not publicly available. Prospective customers are directed to contact the company directly for quotes.

oxygenimaging.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

O2M Technologies develops and sells the JIVA-25®, the world's first dedicated preclinical oxygen imager, which uses pulsed electron paramagnetic resonance oxygen imaging (EPROI) to non-invasively map absolute tissue oxygen (pO₂) at approximately 0.5 mm resolution. The company complements the instrument with Trityl OXO71 and OXO63 water-soluble contrast agents, the LiteAPM™ small-animal physiological monitor, and the Oxygen Measurement Core contract research service for academic and pharmaceutical partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • ~0.5 mm spatial resolution for tissue oxygen mapping
+2 more records
Product overview1 text field

O2M Technologies offers a portfolio of oxygen imaging products and services for biomedical research. The core product is the JIVA-25® — the world's first dedicated preclinical oxygen imager that produces absolute tissue oxygen (pO₂) maps at ~0.5 mm resolution using pulsed electron paramagnetic resonance oxygen imaging (EPROI) technology. This is complemented by Trityl OXO71 & OXO63 contrast agents (water-soluble, non-toxic consumables), the LiteAPM™ physiological monitor for small-animal monitoring, and the Oxygen Measurement Core contract research service providing in vitro and in vivo oxygen measurement services for academic and industry partners.

Product and service4 records
1JIVA-25®
CategoryPreclinical imaging instruments
Description

The JIVA-25 is the world's first dedicated preclinical oxygen imager. It produces absolute pO₂ maps with 1 mmHg resolution in 1–10 minutes using pulsed electron paramagnetic resonance oxygen imaging (EPROI) and is sold to academic research institutions, foundations, and pharmaceutical/biotech companies for tumor hypoxia, therapy response, and drug development studies.

2Trityl OXO71 & OXO63 Contrast Agents
CategoryImaging consumables
Description

Water-soluble, non-toxic oxygen-imaging Trityl contrast agents (OXO71 and OXO63) sold as powder or stock solution and used with the JIVA-25 instrument for EPR oxygen imaging. These consumables are purchased by existing JIVA-25 customers in academic, foundation, and pharmaceutical/biotech settings as recurring inputs for preclinical oxygen studies.

3LiteAPM™
CategoryPreclinical imaging accessories
Description

The LiteAPM is a 184-gram transportable small-animal physiological monitor that tracks temperature and breathing during surgery, imaging, and transfers. It is sold as an accessory to JIVA-25 users and other preclinical imaging laboratories requiring lightweight, transportable vital-sign monitoring for small animals.

4Oxygen Measurement Core
CategoryContract research services
Description

The Oxygen Measurement Core is O2M's contract research service that delivers complete in vitro and small animal in vivo oxygen measurement studies on the JIVA-25, spanning sample preparation through publication-quality data output. The service is offered to academic researchers, scientific foundations, and pharmaceutical/biotech industry partners who need EPROI oxygen data without operating the instrumentation themselves.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Bruker is the leading manufacturer of EPR spectrometers and preclinical MRI systems, including ELEXSYS and Biospec product lines that compete with O2M's JIVA-25 in EPR-based measurement for biomedical research. Bruker is a broad incumbent across scientific instruments with overlap in the core technology platform.

TypeDirect peer
Description

LI-COR manufactures preclinical optical and infrared imaging systems (Pearl Trilogy, Odyssey CLx) used in small-animal cancer and metabolism research. Both companies sell dedicated preclinical imaging capital equipment plus consumables to overlapping academic and pharma research customers.

TypeBroad incumbent
Description

PerkinElmer/Revvity's life sciences segment supplies preclinical imaging reagents, IVIS optical imaging systems, and laboratory analytical instruments to academic and pharma R&D customers. The company addresses an overlapping customer base with broader portfolio positioning.

TypeDirect peer
Description

Aspect Imaging produces compact, easy-to-site preclinical MRI systems (M-series) targeting the same dedicated preclinical imaging niche as O2M's JIVA-25, with comparable positioning around accessible, dedicated bench-top form factors for biomedical research labs.

TypeDirect peer
Description

MR Solutions designs preclinical MRI and PET/MR systems for small-animal imaging used in cancer and drug development research, overlapping with O2M's preclinical imaging value proposition and academic/biopharma customer base.

TypeDirect peer
Description

Mediso manufactures preclinical PET, SPECT, and CT imaging systems (nanoScan) used by cancer researchers and pharma drug development groups globally. It addresses the same dedicated preclinical imaging category with multi-modality instrumentation.

TypeDirect peer
Description

Oxford Instruments Andor division supplies scientific detectors, spectroscopy cameras, and microscopy imaging platforms used in biomedical EPR and oxygen research. Both companies serve the analytical/measurement instrumentation workflow for biomedical labs.

TypeEmerging player
Description

Miltenyi Biotec provides preclinical imaging and cell-analysis workflows (MACS, gentleMACS, ultra-high-field MRI) for translational and preclinical research. It overlaps with O2M's pharma/biotech translational customer base and dedicated instrument sales motion.

TypeRegional player
Description

Scintica is a specialized distributor and integration partner for preclinical imaging modalities (ultrasound, photoacoustic, MRI) into the North American research market, comparable to O2M's dedicated preclinical instrument go-to-market through direct academic/pharma sales.

TypeEmerging player
Description

Active Spectrum produces bench-top EPR spectrometers for chemistry, catalysis, and emerging biomedical applications. It overlaps with O2M's EPR core-technology base and dedicated bench-top preclinical instrument positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

O2M Technologies

Preclinical Oxygen Imaging Instrumentso2map.com

O2M Technologies, LLC develops oxygen imaging devices and services for cancer research, regenerative medicine, and preclinical drug development, anchored by the JIVA-25, the world's first dedicated preclinical oxygen imager using pulsed electron paramagnetic resonance technology. It sells instruments, proprietary contrast agents, and contract research services to academic and pharmaceutical customers.

What O2M Technologies does

O2M Technologies, LLC is a Chicago-based private company that develops oxygen imaging devices and services for cancer research, regenerative medicine, and drug development. The company's foundational technology is pulsed electron paramagnetic resonance oxygen imaging (EPROI), a non-invasive method that maps absolute tissue oxygen (pO2) at approximately 0.5 mm spatial resolution using a water-soluble, non-toxic trityl spin probe. The company describes itself as the world leader in EPR oxygen imaging and its application to biomedical fields.

O2M's commercial portfolio centers on the JIVA-25®, positioned as the world's first dedicated preclinical oxygen imager, which produces absolute pO2 maps with 1 mmHg sensitivity in 1–10 minutes. The instrument is complemented by a consumables line — Trityl OXO71 and OXO63 water-soluble contrast agents — and by LiteAPM™, a 184-gram transportable small-animal physiological monitor used during imaging and surgery workflows. Together, these products constitute an integrated imaging + consumables + accessories platform for preclinical oxygen measurement.

O2M generates revenue through three streams: one-time sales of JIVA-25 instruments (capital equipment), recurring sales of Trityl contrast agents (consumables), and contract research services delivered through its Oxygen Measurement Core facility, which provides in vitro and small animal in vivo oxygen measurement from sample preparation through publication-quality data. The company pursues a sales-led go-to-market targeting academic and foundation research institutions, cancer research centers, and pharmaceutical and biotech companies. Pricing is quote-based across instruments, consumables, and services and is not publicly disclosed. Cumulative disclosed funding totals approximately $1.2 million across two NSF grants (2018 and 2021); no equity funding, named customers, or revenue figures have been disclosed.

O2M Technologies firmographics

Firmographics
Name
O2M Technologies
Legal name
O2M Technologies, LLC
Website
https://o2map.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
O2M Technologies, LLC develops oxygen imaging devices and services for cancer research, regenerative medicine, and preclinical drug development, anchored by the JIVA-25, the world's first dedicated preclinical oxygen imager using pulsed electron paramagnetic resonance technology. It sells instruments, proprietary contrast agents, and contract research services to academic and pharmaceutical customers.
Ownership category
akta.pro rank

O2M Technologies industry classification

Industry
Product category
Preclinical Oxygen Imaging Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417)
SIC
Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAHAGAI
Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

Keywords

  • Preclinical oxygen imaging
  • Electron paramagnetic resonance
  • Tissue oxygen mapping
  • Contrast agent imaging
  • Small animal imaging

Where O2M Technologies is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Offices1 record

Markets served

O2M Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. Scientific Instruments (JIVA-25®): Sale of specialized preclinical oxygen imaging instruments to research institutions and pharmaceutical companies. This represents the primary capital equipment revenue stream.
  2. Consumables (Trityl Contrast Agents): Recurring revenue from Trityl OXO71 and OXO63 contrast agents sold as powder or stock solution to existing JIVA-25 customers.
  3. Contract Research Services (Oxygen Measurement Core): Contract research facility offering complete in vitro and small animal in vivo oxygen measurement services — from sample prep through publication-quality data for academic, foundation, and industry partners.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based pricing for all products and services

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

O2M Technologies product offering

Product offering

Core offering

O2M Technologies develops and sells the JIVA-25®, the world's first dedicated preclinical oxygen imager, which uses pulsed electron paramagnetic resonance oxygen imaging (EPROI) to non-invasively map absolute tissue oxygen (pO₂) at approximately 0.5 mm resolution. The company complements the instrument with Trityl OXO71 and OXO63 water-soluble contrast agents, the LiteAPM™ small-animal physiological monitor, and the Oxygen Measurement Core contract research service for academic and pharmaceutical partners.

Product overview

O2M Technologies offers a portfolio of oxygen imaging products and services for biomedical research. The core product is the JIVA-25® — the world's first dedicated preclinical oxygen imager that produces absolute tissue oxygen (pO₂) maps at ~0.5 mm resolution using pulsed electron paramagnetic resonance oxygen imaging (EPROI) technology. This is complemented by Trityl OXO71 & OXO63 contrast agents (water-soluble, non-toxic consumables), the LiteAPM™ physiological monitor for small-animal monitoring, and the Oxygen Measurement Core contract research service providing in vitro and in vivo oxygen measurement services for academic and industry partners.

Differentiator

Problem solved

Functional benefit

Products and services

  • JIVA-25® The JIVA-25 is the world's first dedicated preclinical oxygen imager. It produces absolute pO₂ maps with 1 mmHg resolution in 1–10 minutes using pulsed electron paramagnetic resonance oxygen imaging (EPROI) and is sold to academic research institutions, foundations, and pharmaceutical/biotech companies for tumor hypoxia, therapy response, and drug development studies.
  • Trityl OXO71 & OXO63 Contrast Agents Water-soluble, non-toxic oxygen-imaging Trityl contrast agents (OXO71 and OXO63) sold as powder or stock solution and used with the JIVA-25 instrument for EPR oxygen imaging. These consumables are purchased by existing JIVA-25 customers in academic, foundation, and pharmaceutical/biotech settings as recurring inputs for preclinical oxygen studies.
  • LiteAPM™ The LiteAPM is a 184-gram transportable small-animal physiological monitor that tracks temperature and breathing during surgery, imaging, and transfers. It is sold as an accessory to JIVA-25 users and other preclinical imaging laboratories requiring lightweight, transportable vital-sign monitoring for small animals.
  • Oxygen Measurement Core The Oxygen Measurement Core is O2M's contract research service that delivers complete in vitro and small animal in vivo oxygen measurement studies on the JIVA-25, spanning sample preparation through publication-quality data output. The service is offered to academic researchers, scientific foundations, and pharmaceutical/biotech industry partners who need EPROI oxygen data without operating the instrumentation themselves.

Quantifiable outcome

  • ~0.5 mm spatial resolution for tissue oxygen mapping
  • +2 more outcomes

Companies that use O2M Technologies

Customer profile

Segments3 records

Ideal customer profiles3 records

O2M Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

O2M Technologies partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

O2M Technologies competitors and assessment

Company assessment

Broad incumbents

  • Bruker Corporation: Bruker is the leading manufacturer of EPR spectrometers and preclinical MRI systems, including ELEXSYS and Biospec product lines that compete with O2M's JIVA-25 in EPR-based measurement for biomedical research. Bruker is a broad incumbent across scientific instruments with overlap in the core technology platform.
  • PerkinElmer (Revvity): PerkinElmer/Revvity's life sciences segment supplies preclinical imaging reagents, IVIS optical imaging systems, and laboratory analytical instruments to academic and pharma R&D customers. The company addresses an overlapping customer base with broader portfolio positioning.

Direct peers

  • LI-COR Biosciences: LI-COR manufactures preclinical optical and infrared imaging systems (Pearl Trilogy, Odyssey CLx) used in small-animal cancer and metabolism research. Both companies sell dedicated preclinical imaging capital equipment plus consumables to overlapping academic and pharma research customers.
  • Aspect Imaging: Aspect Imaging produces compact, easy-to-site preclinical MRI systems (M-series) targeting the same dedicated preclinical imaging niche as O2M's JIVA-25, with comparable positioning around accessible, dedicated bench-top form factors for biomedical research labs.
  • MR Solutions: MR Solutions designs preclinical MRI and PET/MR systems for small-animal imaging used in cancer and drug development research, overlapping with O2M's preclinical imaging value proposition and academic/biopharma customer base.
  • Mediso Medical Imaging Systems: Mediso manufactures preclinical PET, SPECT, and CT imaging systems (nanoScan) used by cancer researchers and pharma drug development groups globally. It addresses the same dedicated preclinical imaging category with multi-modality instrumentation.
  • Oxford Instruments (Andor): Oxford Instruments Andor division supplies scientific detectors, spectroscopy cameras, and microscopy imaging platforms used in biomedical EPR and oxygen research. Both companies serve the analytical/measurement instrumentation workflow for biomedical labs.

Emerging players

  • Miltenyi Biotec: Miltenyi Biotec provides preclinical imaging and cell-analysis workflows (MACS, gentleMACS, ultra-high-field MRI) for translational and preclinical research. It overlaps with O2M's pharma/biotech translational customer base and dedicated instrument sales motion.
  • Active Spectrum: Active Spectrum produces bench-top EPR spectrometers for chemistry, catalysis, and emerging biomedical applications. It overlaps with O2M's EPR core-technology base and dedicated bench-top preclinical instrument positioning.

Regional players

  • Scintica Instrumentation: Scintica is a specialized distributor and integration partner for preclinical imaging modalities (ultrasound, photoacoustic, MRI) into the North American research market, comparable to O2M's dedicated preclinical instrument go-to-market through direct academic/pharma sales.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

O2M Technologies social profiles

Digital presence

O2M Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

O2M Technologies leadership team

Management profile

Number of profiles

Profiles1 record

O2M Technologies funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

O2M Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about O2M Technologies

What does O2M Technologies do?

O2M Technologies develops and sells the JIVA-25®, the world's first dedicated preclinical oxygen imager, which uses pulsed electron paramagnetic resonance oxygen imaging (EPROI) to non-invasively map absolute tissue oxygen (pO₂) at approximately 0.5 mm resolution. The company complements the instrument with Trityl OXO71 and OXO63 water-soluble contrast agents, the LiteAPM™ small-animal physiological monitor, and the Oxygen Measurement Core contract research service for academic and pharmaceutical partners.

Is O2M Technologies a public or private company?

O2M Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was O2M Technologies founded?

O2M Technologies was founded in 2017. It employs 11 to 50 people.

Where is O2M Technologies based?

O2M Technologies is headquartered in Chicago, United States, in the North America region.

How does O2M Technologies make money?

Three revenue lines are on record. Scientific Instruments (JIVA-25®) is the primary driver. The others are consumables (Trityl Contrast Agents) and contract Research Services (Oxygen Measurement Core).

Who are O2M Technologies's main competitors?

Broad incumbents on record are Bruker Corporation and PerkinElmer (Revvity). Direct peers are LI-COR Biosciences, Aspect Imaging, MR Solutions, Mediso Medical Imaging Systems and Oxford Instruments (Andor). Emerging players are Miltenyi Biotec and Active Spectrum. Scintica Instrumentation is listed as a regional player.

Does O2M Technologies have an API?

No public API is recorded for O2M Technologies.

What industry is O2M Technologies in?

O2M Technologies's product category is Preclinical Oxygen Imaging Instruments. Its primary akta.pro industry code is HLAHAGAI, Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales